FoxMeyer Drug declares bankruptcy after sale falls through
FoxMeyer Drug Co., the nation's fourth-largest wholesaler of drugs, said Tuesday it filed for Chapter 11 bankruptcy protection after efforts to sell the ailing company fell through.
FoxMeyer Health Corp. said last week it was in final negotiations to sell FoxMeyer Drug to a New Jersey investor group led by William F. Taggart, a turnaround expert, for $25 million in cash and securities
The subsidiary accounts for most of FoxMeyer Health's $5.5 billion in annual revenue.
FoxMeyer did not say why the sale was terminated.
FoxMeyer Drug also announced the appointment of Robert Peiser as the drug unit's vice chairman and chief executive.
